Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the blood plasma derivatives market grown in recent years?

The size of the blood plasma derivatives market has been expanding robustly in the past years. The market, which is poised to surge from $51.81 billion in 2024 to $56.24 billion in 2025, will record a compound annual growth rate (CAGR) of 8.6%. Factors that have prompted growth during the historic period include the escalating prevalence of hemophilia and bleeding disorders, an increase in the elderly population, enhanced awareness and diagnosis, a surge in surgical procedures, and the growth of global blood transfusion services.

How is the blood plasma derivatives market size expected to evolve during the forecast period?

The market for blood plasma derivatives is set to experience robust expansion in the coming years, with its worth projected to reach $80.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. This predicted growth in the forecast phase can be accredited to the rise of therapies for rare diseases, an increase in chronic illnesses, amplified healthcare expenditure, patient-focused treatment methodologies, and the expansion of healthcare infrastructure. Key trends anticipated during the forecast period consist of progress in fractionation technologies, patient-focused strategies, collaborations and partnerships, growing uses in the field of neurology, and technological breakthroughs in plasma fractionation.

Get your blood plasma derivatives market report here!

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Which key drivers are propelling the blood plasma derivatives market’s growth?

The growth of the blood plasma derivatives market is anticipated to be propelled by the rising occurrence of immunodeficiency disorders. These diseases either completely or partially impair the immune system. Blood plasma derivatives are extensively employed in the treatment of a host of medical conditions, including immune deficiency disorders. Plasma, which is a mixture of proteins and salts, contains over 100 different proteins. Among these, immunoglobulins are specifically used for managing primary immunodeficiencies. Malnutrition or insufficient nutrition causes deficiencies in macro and micronutrients, leading to immunodeficiency. For example, the Allergy, Asthma & Clinical Immunology reported in March 2022 that the most frequent disorder was Common Variable Immunodeficiency (CVID), affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% globally. Hence, the escalating prevalence of immune deficiency disorders is fueling the growth of the blood plasma derivatives market.

What are the market segments in the blood plasma derivatives industry?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Which leading companies are shaping the growth of the blood plasma derivatives market?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

What key trends are currently impacting the blood plasma derivatives market’s development?

Major players in the blood plasma derivatives market are concentrating on forming strategic alliances to secure a competitive position. This collaboration ensures that patients have a reliable, consistent source of essential plasma-derived medications, addressing the growing demand for immunoglobulins both in France and globally. For example, in January 2022, Kedrion S.p.A., a biopharmaceutical company from Italy that focuses on developing, manufacturing, and distributing plasma-derived therapies, formed a partnership with LPB, a UK-based company that specializes in biological medicinal products. Kedrion will process LFB plasma, acquired in France by the Etablissement Français du Sang (EFS), in Hungary to create immunoglobulins. The existing immunoglobulin supply, which is provided to hospitals nationwide, monitored and guided by French health authorities, will be bolstered by these imports from LFB in France.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

Which geographic areas are influencing the growth of the blood plasma derivatives market?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Electrolyte Mixes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrolyte-mixes-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Hemostasis Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: